» Articles » PMID: 24875096

Dynamic Alterations in Hippo Signaling Pathway and YAP Activation During Liver Regeneration

Overview
Date 2014 May 31
PMID 24875096
Citations 79
Authors
Affiliations
Soon will be listed here.
Abstract

The Hippo signaling pathway has been implicated in mammalian organ size regulation and tumor suppression. Specifically, the Hippo pathway plays a critical role regulating the activity of transcriptional coactivator Yes-associated protein (YAP), which modulates a proliferative transcriptional program. Recent investigations have demonstrated that while this pathway is activated in quiescent livers, its inhibition leads to liver overgrowth and tumorigenesis. However, the role of the Hippo pathway during the natural process of liver regeneration remains unknown. Here we investigated alterations in the Hippo signaling pathway and YAP activation during liver regeneration using a 70% partial hepatectomy (PH) rat model. Our results indicate an increase in YAP activation by 1 day following PH as demonstrated by increased YAP nuclear localization and increased YAP target gene expression. Investigation of the Hippo pathway revealed a decrease in the activation of core kinases Mst1/2 by 1 day as well as Lats1/2 and its adapter protein Mob1 by 3 days following PH. Evaluation of liver-to-body weight ratios indicated that the liver reaches its near normal size by 7 days following PH, which correlated with a return to baseline YAP nuclear levels and target gene expression. Additionally, when liver size was restored, Mst1/2 kinase activation returned to levels observed in quiescent livers indicating reactivation of the Hippo signaling pathway. These findings illustrate the dynamic changes in the Hippo signaling pathway and YAP activation during liver regeneration, which stabilize when the liver-to-body weight ratio reaches homeostatic levels.

Citing Articles

[Inhibiting Yes-associated protein alleviates CCl liver fibrosis in mice by reducing epithelial mesenchymal transition].

Zhao W, Ruan H, Wang S, Cheng Y, Lei M, Zhao J Nan Fang Yi Ke Da Xue Xue Bao. 2024; 44(10):1839-1849.

PMID: 39523083 PMC: 11526463. DOI: 10.12122/j.issn.1673-4254.2024.10.01.


ALKBH5 Protects Against Hepatic Ischemia-Reperfusion Injury by Regulating YTHDF1-Mediated YAP Expression.

Wang P, Xiang M, Zhu L, Zhang R, Zheng X, Zheng Z Int J Mol Sci. 2024; 25(21).

PMID: 39519091 PMC: 11546256. DOI: 10.3390/ijms252111537.


Sex hormone receptors, calcium-binding protein and Yap1 signaling regulate sex-dependent liver cell proliferation following partial hepatectomy.

Zhu M, Li Y, Shen Q, Gong Z, Liu D Dis Model Mech. 2024; 17(10).

PMID: 39397390 PMC: 11556313. DOI: 10.1242/dmm.050900.


Cell competition in primary and metastatic colorectal cancer.

van Luyk M, Krotenberg Garcia A, Lamprou M, Suijkerbuijk S Oncogenesis. 2024; 13(1):28.

PMID: 39060237 PMC: 11282291. DOI: 10.1038/s41389-024-00530-5.


Fenofibrate-promoted hepatomegaly and liver regeneration are PPAR-dependent and partially related to the YAP pathway.

Fan S, Gao Y, Zhao P, Xie G, Zhou Y, Yang X Acta Pharm Sin B. 2024; 14(7):2992-3008.

PMID: 39027236 PMC: 11252459. DOI: 10.1016/j.apsb.2024.03.030.